<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03414164</url>
  </required_header>
  <id_info>
    <org_study_id>UHR-12</org_study_id>
    <nct_id>NCT03414164</nct_id>
  </id_info>
  <brief_title>In Vitro Effects of Procyanidine on Semen Parameter and DFI</brief_title>
  <official_title>In Vitro Effects of Procyanidine on Semen Parameters and DNA Fragmentation Index: a Prospective, Double-blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proanthocyanidins are a class of polyphenols found in a variety of plants that have&#xD;
      antioxidant activity in vitro, which is stronger than vitamin C or vitamin E.&#xD;
&#xD;
      Several studies have been performed evaluating the administration of antioxidant therapy in&#xD;
      the form of oral antioxidant supplementation or in vitro addition of antioxidant to culture&#xD;
      media during assisted reproductive techniques (ART).&#xD;
&#xD;
      However, the impact of in vitro addition of proanthocyanidins to semen has not been studied&#xD;
      yet. The research question evaluated in the current study was whether semen samples of&#xD;
      infertile men supplemented or not with procyanidine immediately after their production,&#xD;
      differ in semen parameters, sperm DFI.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 29, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">November 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progressive sperm motility</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sperm DNA fragmentation index</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm morphology</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm vitality</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Spermatogenesis and Semen Disorders</condition>
  <condition>DNA Double Strand Break</condition>
  <arm_group>
    <arm_group_label>procyanidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>procyanidine</intervention_name>
    <description>natural antioxidants</description>
    <arm_group_label>procyanidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infertility defined as:&#xD;
&#xD;
               -  At least twelve (12) months of non-achieving pregnancy despite unprotected sexual&#xD;
                  intercourse or six (6) months, if the female is &gt; 35 years of age AND&#xD;
&#xD;
               -  At least two (2) semen analyses with at least one abnormal parameter (sperm&#xD;
                  concentration, motility and morphology), according to WHO 2010 criteria.&#xD;
&#xD;
          -  Not on any type of infertility treatment for the last three (3) months&#xD;
&#xD;
          -  Sperm concentration &gt; 8 x 106/ml and semen volume at least 2.5 ml for technical&#xD;
             reasons.&#xD;
&#xD;
          -  Normal hormonal profile (TSH, FSH, LH, total testosterone, prolactin)&#xD;
&#xD;
          -  Seminal white blood cells &lt; 1 x 106/ml&#xD;
&#xD;
          -  No abnormalities in scrotal ultrasound&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Underlying genetic cause of infertility&#xD;
&#xD;
          -  History of undescended testis (cryptorchidism)&#xD;
&#xD;
          -  History of orchidectomy&#xD;
&#xD;
          -  History of testicular cancer&#xD;
&#xD;
          -  History of severe cardiac, hepatic or renal disease.&#xD;
&#xD;
          -  History of endocrine disease (primary or secondary hypogonadism, hyperprolactinemia,&#xD;
             thyroid disease, pituitary or adrenal disease)&#xD;
&#xD;
          -  History of epididymo-orchitis, prostatitis, genital trauma, testicular torsion,&#xD;
             inguinal or genital surgery&#xD;
&#xD;
          -  History of systemic disease or treatment during the last three (3) months&#xD;
&#xD;
          -  Positive sperm culture for Chlamydia or Ureaplasma urealyticum&#xD;
&#xD;
          -  Female infertility factors&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 30 kg/m2&#xD;
&#xD;
          -  Participation in another interventional study and a likelihood of being unavailable&#xD;
             for follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stratis Kolibianakis</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54603</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>E.M. Kolibianakis</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Procyanidin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

